Cholesterol Testing Services Market with Elucidates Potential Revenue Opportunity Across Different Segments | Quest Diagnostics Incorporated, Spectra Laboratories, Bio-Reference Laboratories, Eurofins Scientific (Luxembourg)

Cholesterol helps to make the outer layer of the cells in body, produce bile acids, which help in digestion and absorption of dietary fats. However, high cholesterol in the blood, could lead to development of fatty patches on the walls of blood vessels, known as atheroma. Blood testing is the only way to check cholesterol levels in the body. The Adult Treatment Panel of the National Cholesterol Education Program (NCEP) recommends that all adults aged 20 years and above should have a fasting lipoprotein profile (total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride) tested, once every five years, to screen for coronary heart disease risk. Such initiatives from organizations is expected to aid in positive growth of the global cholesterol testing service market.

Download PDF Brochure of This Business Research Report@ https://www.coherentmarketinsights.com/insight/request-pdf/1376

The global cholesterol testing services market was valued at US$ 11.5 Bn in 2016 and is expected to witness a CAGR of 7.8% over the forecast period (2017–2025).

Market Dynamics

Increasing prevalence of high cholesterol among population is expected to drive growth of the market in the near future. For instance, according to American Heart Association, around 7.8% of adolescents aged 12—19 years have total cholesterol levels ≥200 mg/dL, and about 98.9 million people in the U.S. aged 20 years and above have total blood cholesterol levels of 200 milligrams per deciliter (mg/dL) in 2013. Furthermore, increasing geriatric and obese population is also expected to drive demand for cholesterol testing services as the prevalence of high cholesterol is more in aged and obese population. For instance, according to Economic and Social Commission for Asia and the Pacific (ESCAP) in 2016, around 12.4% of the population in the Asia Pacific region was aged 60 years or above, which is expected to reach 1.3 billion people by 2050. According to a study published by The Organisation for Economic Co-operation and Development (OECD) in 2015, across the OECD, 19.5% of the adult population was reported obese. This rate ranges from less than 6% in Korea and Japan to over 30% in Hungary, New Zealand, Mexico, and the U.S. over one in four adults is reported obese in Australia, Canada, Chile, South Africa, and the U.K.

According to a research published by National Heart Foundation of Australia, in 2012, around 5.6 million people aged 18 years and above were reported to have high total cholesterol levels in Australia. High blood cholesterol could lead to risk for developing various heart diseases and stroke, owing to which, people are opting for regular cholesterol checkups. This is expected to increase demand for its testing thus, driving growth of the market in the near future. Furthermore, cholesterol level in plasma increases with age, according to a study published in NCBI in 2013. Hence, rising geriatric population and increasing prevalence of obesity are also expected to be factors aiding in market growth. This is due to high susceptibility of obese and geriatric population to increasing cholesterol levels. For instance, according to a study published by World Health Organization (WHO) in 2014, globally, over 1.9 billion adults aged 18 years and above were overweight, from which over 600 million adults were obese. According to National Institute of Health (NIH) in 2016, around 8.5%, which is 617 million of the world population, is aged 65 and above.

According to a study published in Centers for Disease Control and Prevention in 2014, the prevalence of obesity was around 36.5% among adults in the U.S. Prevalence of obesity among middle-aged adults aged 40–59 (40.2%) years and older adults aged 60 and above years (37.0%) was higher than among younger adults aged 20–39 (32.3%), prevalence of obesity among women (38.3%) was higher than among men (34.3%) in U.S. Furthermore, increasing awareness among population regarding regular health checkup in both developed and emerging economies is expected to fuel growth of the global cholesterol testing services market.

Key players operating in the global cholesterol testing services market include Quest Diagnostics Incorporated, Spectra Laboratories Inc., Bio-Reference Laboratories Inc., Eurofins Scientific (Luxembourg), Clinical Reference Laboratory, Inc. (CRL), ACM Medical Laboratory, Adicon Clinical Laboratory, Unilabs, SYNLAB International GmbH, and Laboratory Corporation of America Holdings (LabCorp).

Request For Customization Of This Business Research Report@ https://www.coherentmarketinsights.com/insight/request-customization/1376

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.